Listed

Celularity Inc: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 16, 2020 and accepted by EDGAR at Nov 16, 2020, 10:21 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2020-07-01 to 2020-09-30−$208.3kus-gaap:OperatingIncomeLoss
Operating income9 months2020-01-01 to 2020-09-30−$658.2kus-gaap:OperatingIncomeLoss
Income tax3 months2020-07-01 to 2020-09-30−$10.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2020-01-01 to 2020-09-30$224.5kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-07-01 to 2020-09-30−$37.5kus-gaap:NetIncomeLoss
Net income9 months2020-01-01 to 2020-09-30$843.6kus-gaap:NetIncomeLoss
Operating cash flow9 months2020-01-01 to 2020-09-30−$938.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2020-09-30$454.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-09-30$520.4kus-gaap:AssetsCurrent
Total assetsAt period end2020-09-30$292.4mus-gaap:Assets
Current liabilitiesAt period end2020-09-30$141.3kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-09-30$11.0mus-gaap:Liabilities
Shareholders' equityAt period end2020-09-30$5.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-20-037167. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.